Antibiotic resistance: an increasing problem?
BMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7140.1255 (Published 25 April 1998) Cite this as: BMJ 1998;316:1255
All rapid responses
Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
EDITOR-The editorial by Hart1 is timely. We would strongly support the need to increase undergraduate and postgraduate medical education in the appropriate use of antimicrobials. It is unfortunate that the news item ‘Report calls for action on antibiotic treatment’ (p 1261, 25 April) is opposite a full-page advertisement for an antibiotic. Furthermore, the advertisement appears to promote the use of a new fluoroquinolone to treat community respiratory infections ‘even (due to) Streptococcus pneumoniae’. The majority of strains of S pneumoniae remain
penicillin-sensitive and there is little evidence that quinolones are needed to treat acute sinusitis or acute exacerbations of chronic bronchitis.
It is also unfortunate that the only other advertisement for an antibiotic in the 25 April edition occurs in the midst of a paper describing meta-analysis of antibiotic prophylaxis in the critically ill 2.
The presence of these advertisements emphasises the likely difficulty in changing patterns of antibiotic prescribing.
1. Hart CA. Antibiotic resistance: an increasing problem? BMJ 1998;316:1255-6.(25 April)
2. D’Amico RD, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998;316:1275-85. (25 April)
Philip Pearson, Senior House Officer
Paul McWhinney, Locum Consultant Physician
Philip Stanley, Consultant Physician
Regional Department of Adult & Paediatric Infectious Diseases
Seacroft Hospital, Leeds, LS14 6UH
Tel: 0113 206 3322
Fax: 0113 206 2132
Competing interests: No competing interests
Antibiotic resistance
Dear Sir,
Evidence is now available to the effect that continued use of a
given antibiotic for control and/or degradation of bacterial
populations in mammalian metabolisms eventually results in a
decrease in the extent of control. The origin of this phenomenon is
presently considered to be the presence in any bacterial
population of alternative forms, or the generation of alternative
forms, of the bacteria which produce chemical compounds which
degrade the antibiotic being used. In the case of penicillin for
example such versions of the bacteria involved are advanced as
capable of developing the capacity to produce b-lactamase
(penicillinase) when brought into contact with penicillin.
It is
proposed that penicillin is destroyed by b-lactamase. Although
some bacteria produce this compound this is not the case for most
bacteria. Penicillinase-resistant b-lactam antibiotics such as
methicillin have been developed. However resistance to these has
also arisen. Penicillium chrysogenum is a mold that is widely
distributed in nature and is the source of penicillin and several
other b-lactam antibiotics which allow the mold to be active against
several bacteria. As stated only a few bacteria in nature exhibit b-
lactam resistance. On the basis that this mold and bacteria have
been interacting for millennia the absence of a widespread
development of b-lactam resistance among bacteria in nature
indicates that the development of this phenomena is the result of
either the different chemical environment of the mammalian
metabolism and/or that the mammalian metabolism contains a
factor or factors either absent from or present in the latter
environment. The fact that Penicillium chrysogenum produces a
family of b-lactams only one of which is separated and used in
mammalian metabolisms is the possible reason for the
development of antibiotic resistance in these systems. The family
of antibiotics produced and used simultaneously against bacteria
in nature by molds ensures that degradation of susceptible
bacteria takes place from several chemical directions. The
persistent use of a single member of the Penicillium chrysogenum
family of b-lactams means that an alteration in bacterial cell
chemical reactions can lead to the the incorporation of derivatives
of penicillin as part of the cell structure. For example penicillin may
be regarded as being derived from D-bb-Methylcysteine and the
N-acetyl derivatives of serine aldehyde which have combined to
form thio-amino acetals (penicilloic acids), followed by dehydration
to give the b-lactam. Hydrolysis, the reversal of this process, is
likely to result in the reformation of these compounds which are
amino acids and can be incorporated into the structure of cell
proteins without having any effect. Persistent long term contact
with penicillin can also lead to the alteration of the chemical
reactions in a bacterial cell giving rise to a novel products. Such
contact can occur under conditions where the concentration of
penicillin is below that required for effective degradation of a
bacterial cell. The continued division of the bacterial cell further
reduces the concentration of antibiotic compound by factor of two
after each division (e.g. after 10 divisions the concentration in any
part of a bacterium is reduced by a factor of one thousand)
although the concentration is never reduced to zero. The
persistence of these low concentration conditions over an
extended period of time accompanied by withdrawal of contact
with higher concentrations of penicillin means the bacteria
involved can incorporate the antibiotic or the products of antibiotics
into the cellular chemical reactions giving rise to novel cell
compounds, one of which is b-lactamase. In Penicillium
chrysogenum the simultaneous presence of a family of b-lactams
inhibits these occurrences almost certainly by the presence of
competing chemical reactions, this being analogous to the use of a
mixture of venoms by some reptiles. It would therefore appear that
the use of a related family of antibiotic compounds all derived from
the same source and not a heterogeneous mixture might well
extend the effective lifetime of the b-lactam antibiotic compounds.
D.S. Robertson , Malvern, Worcestershire, England.
Competing interests:
None declared
Competing interests: No competing interests